Lang, Anthony E.

Initiation of pharmacological therapy in Parkinson's disease: when, why, and how

de Bie, R. M. A., Clarke, C. E., Espay, A. J., Fox, S. H., & Lang, A. E. (2020) · The Lancet Neurology

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 200

Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi‐Omics

Tan, A. H., Chong, C. W., Lim, S., Yap, I. K. S., Teh, C. S. J., Loke, M. F., Song, S., Tan, J. Y., Ang, B. H., Tan, Y. Q., et al. (2021) · Annals of Neurology

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 196

Gut–brain axis and the spread of α‐synuclein pathology: Vagal highway or dead end?

Breen, D. P., Halliday, G. M., & Lang, A. E. (2019) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 193

Premotor Parkinson’s disease: Concepts and definitions

Siderowf, A., & Lang, A. E. (2012) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 174

Caffeine as symptomatic treatment for Parkinson disease (Café-PD): A randomized trial

Postuma, R. B., Anang, J., Pelletier, A., Joseph, L., Moscovich, M., Grimes, D., Furtado, S., Munhoz, R. P., Appel-Cresswell, S., Moro, A., et al. (2017) · Neurology

Parkinson's Disease Mechanisms and TreatmentsCoffee research and impacts

Cited by 135

Impairments of speed and amplitude of movement in Parkinson’s disease: A pilot study

Espay, A. J., Beaton, D. E., Morgante, F., Gunraj, C. A., Lang, A. E., & Chen, R. (2009) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 125

Tics and functional tic-like movements: Can we tell them apart?

Ganos, C., Martino, D., Espay, A. J., Lang, A. E., Bhatia, K. P., & Edwards, M. J. (2019) · Neurology

Obsessive-Compulsive Spectrum DisordersDeep Brain Stimulation and Movement Disorders

Cited by 124

Investing in the future: stimulation of the medial prefrontal cortex reduces discounting of delayed rewards

Cho, S. S., Koshimori, Y., Aminian, K., Obeso, I., Rusjan, P., Lang, A. E., Daskalakis, Z. J., Houle, S., & Strafella, A. P. (2015) · Neuropsychopharmacology

Neural and Behavioral Psychology StudiesTranscranial Magnetic Stimulation Studies

Cited by 112

Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson’s disease

Kim, K. S., Marcogliese, P. C., Yang, J., Callaghan, S. M., Resende, V., Abdel-Messih, E., Marras, C., Visanji, N. P., Huang, J., Schlossmacher, M. G., et al. (2018) · Proceedings of the National Academy of Sciences

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 111

Functional neurological disorders in Parkinson disease

Wissel, B. D., Dwivedi, A. K., Merola, A., Chin, D., Jacob, C., Duker, A. P., Vaughan, J. E., Lovera, L., LaFaver, K., Levy, A., et al. (2018) · Journal of Neurology, Neurosurgery & Psychiatry

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 106

Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy

Martinez-Valbuena, I., Visanji, N. P., Kim, A., Lau, H. H. C., So, R. W. L., Alshimemeri, S., Gao, A., Seidman, M. A., Luquin, M. R., Watts, J. C., et al. (2022) · Translational Neurodegeneration

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

Cited by 103

Imaging Striatal Microglial Activation in Patients with Parkinson’s Disease

Koshimori, Y., Ko, J.-H., Mizrahi, R., Rusjan, P., Mabrouk, R., Jacobs, M. F., Christopher, L., Hamani, C., Lang, A. E., Wilson, A. A., et al. (2015) · PLOS ONE

Neuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and Treatments

Cited by 100

[18F]‐THK5351 PET correlates with topology and symptom severity in progressive supranuclear palsy

Brendel, M., Schönecker, S., Höglinger, G., Lindner, S., Havla, J., Blautzik, J., Sauerbeck, J., Rohrer, G., Zach, C., Vettermann, F., et al. (2018) · Frontiers in Aging Neuroscience

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 72

Peroxisomal D-bifunctional protein deficiency

Lines, M. A., Jobling, R., Brady, L., Marshall, C. R., Scherer, S. W., Rodriguez, A. R., Lee, L., Lang, A. E., Mestre, T. A., Wanders, R. J. A., et al. (2014) · Neurology

Metabolism and Genetic DisordersHereditary Neurological Disorders

Cited by 70

Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative

Sanchez, E., Wilkinson, T., Coughlan, G., Mirza, S., Baril, A., Ramirez, J., Binns, M. A., Black, S. E., Borrie, M., Dilliott, A. A., et al. (2024) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 62